ATTO Attovia Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $52.4M and sold $4.50M on the open market.
Recent ATTO insider trades
- Aug 6, 2026: Goldman Sachs Asset Management, L.P. bought 585,000 shares ($10.3M)
- Aug 6, 2026: Walsh Colin bought 585,000 shares ($10.3M)
- Aug 6, 2026: venBio Global Strategic Fund IV, L.P. bought 382,352 shares ($6.50M)
- Aug 6, 2026: Sanofi bought 300,000 shares ($5.10M)
5%+ owners
- Frazier Life Sciences XI, L.P.: 13.5% (Schedule 13D, filed Aug 11, 2026)
- Deep Track Capital, LP: 7.5% (Schedule 13G, filed Aug 12, 2026)